维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Clemons MJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea显示文摘	McCullough MJ Clemons KV Stevens DA	1999	J Clin Microbiol1999，，2：	1
2	A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy显示文摘	Marshall E Durig J	1998	Blood1998，92，5：	1
3	Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dublini-ensis and Candida stellatoidea显示文摘	McCullough MJ Clemons KV Stevens DA	2010	J Clin Microbiol2010，37，2：	1
4	Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea显示文摘	Mccullough MJ Clemons KV Stevens DA	1999	J Clin Microbiol1999，37，2：	1
5	Intergenic transcribed spacer PCR ribotyping for differentiation of saccharomyces species and interspecific hybrids显示文摘	McCullough MJ Clemons KV McCusker JH	1998	J Clin Microbiol1998，36，4：	1
6	Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours显示文摘	Clemons MJ Bibby MC El Teraifi H	2002	Br J Cancer2002，86，11：	1
7	Molecular and phe-notypic characterization of genotypic Candida albicans subgroupsand comparison with Candida dubliniensis and Candidastellatoidea显示文摘	McCullough MJ Clemons KV Stevens DA	1999	J Clin Microbiol1999，37，2：	1
8	Heterogeneity of O^6-alkylguanine DNA-alkyltransferase expression in human breast tumours显示文摘	Clemons MJ Bibby MC E1 Teraifi H	2002	Br J Cancer2002，86，11：	1
9	Molecular andphenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea显示文摘	Mc Cullough MJ Clemons KV Stevens DA	1999	J Clin Microbiol1999，37，2：	1
10	Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celeeoxib in patients with prior anthracycline exposure for metastatic breast cancer显示文摘	Young SD Lafrenie RM Clemons MJ	2012	Curr Oncol2012，19，2：	1
11	Molecular andphenotypic characterization of genotypic Candida albicanssubgroups and comparison with Candida dubliniensis andCandida stellatoidea显示文摘	McCullough MJ Clemons KV Stevens DA	1999	J Clin Microbiol1999，37，2：	1
12	Phase Ⅱ trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy显示文摘	Clemons MJ Dranitsaris G Ooi WS	2006	J Clin Oncol2006，24，：	1
13	Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubllniensis and Candida steUatoidea显示文摘	McCullough MJ Clemons KV Stevens DA	1999	J Clln Microbiol1999，37，2：	1
14	Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea 显示文摘	Clemons KV Stevens DA	1997	J Clin Microbiol1997，37，：	1
15	Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellato/dea显示文摘	McCullough MJ Clemons KV Stevens DA	1999	J Clin Microbiol1999，37，2：	1
16	Molecular arid phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea 显示文摘	McCullough MJ Clemons KV Stevens DA	1999	J Clin Microbiol1999，37，2：	1
17	Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases显示文摘	Simmons C Miller N Geddie W Gianfelice D Oldfield M Dranitsaris G Clemons MJ	2009	Ann Oncol2009，20，9：	1
18	PhaseⅡtrial evaluat-ing the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy显示文摘	Clemons MJ Dranitsaris G Ooi WS	2006	J Clin Oncol2006，24，30：	1
19	Phase Ⅱ trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy显示文摘	Clemons MJ Dranitsaris G Ooi WS	2006	J Clin Oncol2006，24，30：	1
20	Phase II multicenter trial of anthracycline rechallenge with pegy- lated liposomal doxoruhicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines 显示文摘	Trudeau ME Clemons MJ Provencher L	2009	J Clin Oncol2009，27，35：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示